SEC Form 4 · accession 0000899243-15-004431
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan C. Herman
Officer — Chief Scientific Officer
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Sep 1, 2015 | M | 11,333 | $0.4168 | A | 226,032 | D | |
| Common Stock, $0.0001 par valueF2 | Sep 1, 2015 | S | 6,024 | $27.2307 | D | 220,008 | D | |
| Common Stock, $0.0001 par valueF3 | Sep 1, 2015 | S | 5,309 | $27.5674 | D | 214,699 | D | |
| Common Stock, $0.0001 par valueF4 | holding | — | — | — | 300,164 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $0.4168 | Sep 1, 2015 | M | 11,333 | D | — | Jul 17, 2021 | Common Stock | 11,333 | 80,027 | D |
Explanation of responses
- F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- F2The transaction was executed in multiple trades in prices ranging from $26.42 to $27.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- F3The transaction was executed in multiple trades in prices ranging from $27.43 to $27.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- F4These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.
- F5The shares underlying this option are vested and exercisable as of the date hereof.